ES2055610T3 - Vacuna contra hrsv. - Google Patents

Vacuna contra hrsv.

Info

Publication number
ES2055610T3
ES2055610T3 ES91913753T ES91913753T ES2055610T3 ES 2055610 T3 ES2055610 T3 ES 2055610T3 ES 91913753 T ES91913753 T ES 91913753T ES 91913753 T ES91913753 T ES 91913753T ES 2055610 T3 ES2055610 T3 ES 2055610T3
Authority
ES
Spain
Prior art keywords
vaccine against
hrsv
against hrsv
infections
humans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91913753T
Other languages
English (en)
Inventor
Judith A Nicholas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ES2055610T3 publication Critical patent/ES2055610T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE PRESENTAN PEPTIDOS UTILES PARA PROTEGER A LOS HUMANOS DE LAS INFECCIONES DEL VIRUS HRSV. ASIMISMO SE PRESENTAN VACUNAS QUE COMPRENDEN LOS PEPTIDOS Y UN METODO PARA PROTEGER A LOS HUMANOS DE LAS INFECCIONES POR HRSV.
ES91913753T 1990-08-31 1991-07-30 Vacuna contra hrsv. Expired - Lifetime ES2055610T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57589290A 1990-08-31 1990-08-31

Publications (1)

Publication Number Publication Date
ES2055610T3 true ES2055610T3 (es) 1994-08-16

Family

ID=24302113

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91913753T Expired - Lifetime ES2055610T3 (es) 1990-08-31 1991-07-30 Vacuna contra hrsv.

Country Status (11)

Country Link
EP (1) EP0545951B1 (es)
JP (1) JP3108095B2 (es)
KR (1) KR100227157B1 (es)
AT (1) ATE107661T1 (es)
AU (1) AU644470B2 (es)
CA (1) CA2087003C (es)
DE (1) DE69102649T2 (es)
DK (1) DK0545951T3 (es)
ES (1) ES2055610T3 (es)
HK (1) HK65197A (es)
WO (1) WO1992004375A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2718452B1 (fr) 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
WO1996010400A1 (en) * 1994-09-30 1996-04-11 The Uab Research Foundation Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
US5716821A (en) * 1994-09-30 1998-02-10 Uab Research Foundation Prevention and treatment of respiratory tract disease
FR2726472B1 (fr) 1994-11-07 1997-01-31 Pf Medicament Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
WO2004001425A2 (en) * 2002-06-20 2003-12-31 De Staat Der Nederlanden, Vert. Door De Minister Van Vws Mhc class ii haplotype specific immunodominancy of peptides derived from rsv fusion (f) and attachement (g) proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines

Also Published As

Publication number Publication date
KR100227157B1 (ko) 1999-10-15
JP3108095B2 (ja) 2000-11-13
DK0545951T3 (da) 1994-10-17
CA2087003C (en) 2001-05-08
ATE107661T1 (de) 1994-07-15
DE69102649D1 (de) 1994-07-28
AU8298291A (en) 1992-03-30
CA2087003A1 (en) 1992-03-01
JPH06500536A (ja) 1994-01-20
HK65197A (en) 1997-05-23
WO1992004375A1 (en) 1992-03-19
EP0545951A1 (en) 1993-06-16
EP0545951B1 (en) 1994-06-22
AU644470B2 (en) 1993-12-09
DE69102649T2 (de) 1994-11-03

Similar Documents

Publication Publication Date Title
ES2150493T3 (es) Adyuvantes para vacunas contra el virus sincitico respiratorio.
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
ES2098029T3 (es) Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado.
ES2186809T3 (es) Composiciones de vacunas para administracion intranasal, comprendiendo chitosana y su uso.
ES2134197T3 (es) Vacunas contra el virus del herpes simplex vp16.
FI905184A0 (fi) Kimeriska glykoproteiner som innehaoller immunogeniska delar av human parainfluensa-virus typ 3.
ES2152292T3 (es) Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91.
ATE79548T1 (de) Herpes simplex virus subunitimpfstoff.
ES2104535T1 (es) Vacuna que contiene proteina de membrana externa de bordetella pertussis, y metodo para elaborar tal vacuna.
DK1666057T3 (da) Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener
TW340873B (en) Chicken anaemia agent vaccine
ES2058100T3 (es) Vacuna combinada.
ES2061603T3 (es) Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos.
DE69922212D1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
AR016987A1 (es) Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a
ES2061165T3 (es) Vacuna para la proteccion de las aves de corral frente a la enfermedad de marek.
DE3788986D1 (de) Geflügelcolibacillose-Vakzin.
ATE107661T1 (de) Hrsv-vakzine.
NL7810753A (nl) Gecombineerd vaccin voor immunisering tegen infecties door haemophilus influenza, type b.
FI930519A7 (fi) Peptiidejä HIV-viruksen aiheuttaman infektion torjumiseksi sekä menete lmä niiden käyttämiseksi
ES2080898T3 (es) Procedimiento para la preparacion de una ciclobutanona opticamente activa, un producto intermedio en la sintesis de un nucleosido de ciclobutano opticamente activo.
DK0910405T3 (da) Vaccine, som indeholder caprint arthritis-encephalitis-virus, og anvendelse til immunbeskyttelse imod HIV-1-infektion
MX9303771A (es) Proteina viral icp27 del virus vhs-2, proceso para su preparacion y composicion de vacuna que la incluye.
BR9711138A (pt) Prepara-{es de herperv¡rus equino com prote-Æo mÚtua e m-todo de fazer e usar as mesmas
NZ510130A (en) Chicken anaemia viruses of low pathogenicity

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 545951

Country of ref document: ES